X-Zell is a startup based in Germany.
X-Zell develops a multiplex cytopathology platform that integrates cryofixation, multiplex immunostaining, and hybrid microscopy to provide detailed diagnostic insights from limited cytology samples, primarily for fluid and fine needle aspiration specimens.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.